bioRxivBiochemistryPreprint
Midkine Attenuates Aβ Fibril Assembly and Amyloid Plaque Formation
Masihuz ZamaniD, Shu YangiD, Ya HuangiD, Jay M. YarbroiD, Yanhong HaoiD, Zhen WangiD, Danting LiuiD, Kiara E. Harper, Hadeer Soliman, Alex Hemphill, Sarah Harvey, Shondra M. Pruett‐MilleriD, Valerie Stewart, Ajay Singh TanwariD, Ravi KalathuriD, Christy R. GraceiD, Martin TurkiD, Sagar ChittoriiD, Yun JiaoiD, Zhiping WuiD, Anthony A. HighiD, Xusheng WangiD, Geidy E. SerranoiD, Thomas G. BeachiD, Gang YuiD, , Junmin PengiD
Abstract
Proteomic profiling of Alzheimers disease (AD) brains has identified numerous understudied proteins, including midkine (MDK), that are highly upregulated and correlated with A{beta} since the early disease stage, but their roles in disease progression are not fully understood. Here we present that MDK attenuates A{beta} assembly and influences amyloid formation in the 5xFAD amyloidosis mouse model. MDK protein mitigates fibril formation of both A{beta}40 and A{beta}42 peptides in Thioflavin T fluorescence assay, circular dichroism, negative stain electron microscopy, and NMR analysis. Knockout of Mdk gene in 5xFAD increases amyloid formation and microglial activation. Further comprehensive mass spectrometry-based profiling of whole proteome and detergent-insoluble proteome in these mouse models indicates significant accumulation of A{beta} and A{beta}-correlated proteins, along with microglial components. Thus, our structural and mouse model studies reveal a protective role of MDK in counteracting amyloid pathology in Alzheimers disease.
- organism: mouse
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity
Arun Upadhyay, Deepak Chhangani, … Jeffrey N. Savas·Molecular NeurodegenerationPeer-reviewed·Sep 14, 2023
- Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models
Laura Sebastián Monasor, Stephan A. Müller, … Sabina Tahirović·eLifePeer-reviewed·Jun 8, 2020
- Aβ Amyloid Scaffolds the Accumulation of Matrisome and Additional Proteins in Alzheimer's Disease
Yona Levites, Eric B. Dammer, … Todd Eliot Golde·Cell Reports MedicinePeer-reviewed·Aug 1, 2024
- Ageing-associated myelin dysfunction drives amyloid deposition in mouse models of Alzheimer's disease
Constanze Depp, Ting Sun, … Klaus‐Armin Nave·NaturePeer-reviewed·May 31, 2023
- Two functionally distinct amyloid-β intermediates link aggregation pathways to pathology in Alzheimer's disease
Agnieszka N. Urbanek, Alexander J. Dear, … Suman De·bioRxiv·Oct 1, 2026
- The double-layered structure of amyloid-β assemblage on GM1-containing membranes catalytically promotes fibrillization
M. Yagi-Utsumi, S. G. Itoh, … K. Nishimura·bioRxiv·Jun 26, 2022